Oncogene - Table of Contents alert Volume 36 Issue 17

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 36, Issue 17 (April 2017) In this issue Review Original Articles Oncogenomics Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Review Top Extracellular region of epidermal growth factor receptor: a potential target for anti-EGFR drug discovery A Dokala and S S Thakur Oncogene 2017 36: 2337-2344; advance online publication, October 24, 2016; 10.1038/onc.2016.393 Abstract | Full Text Original Articles Top Metformin alters DNA methylation genome-wide via the H19/SAHH axis OPEN T Zhong, Y Men, L Lu, T Geng, J Zhou, A Mitsuhashi, M Shozu, N J Maihle, G G Carmichael, H S Taylor and Y Huang Oncogene 2017 36: 2345-2354; advance online publication, October 24, 2016; 10.1038/onc.2016.391 Abstract | Full Text p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors A Chiche, M Moumen, M Romagnoli, V Petit, H Lasla, P Jézéquel, P de la Grange, J Jonkers, M-A Deugnier, M A Glukhova and M M Faraldo Oncogene 2017 36: 2355-2365; advance online publication, October 24, 2016; 10.1038/onc.2016.396 Abstract | Full Text Increased FcγRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients M Burgess, S Mapp, R Mazzieri, C Cheung, L Chambers, S R Mattarollo, P Mollee, D Gill and N A Saunders Oncogene 2017 36: 2366-2376; advance online publication, October 17, 2016; 10.1038/onc.2016.387 Abstract | Full Text TAp63 suppresses mammary tumorigenesis through regulation of the Hippo pathway OPEN X Su, M Napoli, H A Abbas, A Venkatanarayan, N H B Bui, C Coarfa, Y J Gi, F Kittrell, P H Gunaratne, D Medina, J M Rosen, F Behbod and E R Flores Oncogene 2017 36: 2377-2393; advance online publication, November 21, 2016; 10.1038/onc.2016.388 Abstract | Full Text HRG/HER2/HER3 signaling promotes AhR-mediated Memo-1 expression and migration in colorectal cancer V Bogoevska, G Wolters-Eisfeld, B T Hofmann, A T El Gammal, B Mercanoglu, F Gebauer, Y K Vashist, D Bogoevski, D Perez, N Gagliani, J R Izbicki, M Bockhorn and C Güngör Oncogene 2017 36: 2394-2404; advance online publication, December 12, 2016; 10.1038/onc.2016.390 Abstract | Full Text Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress K Chroma, M Mistrik, P Moudry, J Gursky, M Liptay, R Strauss, Z Skrott, R Vrtel, J Bartkova, J Kramara and J Bartek Oncogene 2017 36: 2405-2422; advance online publication, November 14, 2016; 10.1038/onc.2016.392 Abstract | Full Text Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway G R Sareddy, S Viswanadhapalli, P Surapaneni, T Suzuki, A Brenner and R K Vadlamudi Oncogene 2017 36: 2423-2434; advance online publication, November 28, 2016; 10.1038/onc.2016.395 Abstract | Full Text DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection H Fan, Z Cui, H Zhang, S K Mani, A Diab, L Lefrancois, N Fares, P Merle and O Andrisani Oncogene 2017 36: 2435-2445; advance online publication, October 31, 2016; 10.1038/onc.2016.399 Abstract | Full Text CAMK2γ antagonizes mTORC1 activation during hepatocarcinogenesis Z Meng, X Ma, J Du, X Wang, M He, Y Gu, J Zhang, W Han, Z Fang, X Gan, C Van Ness, X Fu, D E Schones, R Xu and W Huang Oncogene 2017 36: 2446-2456; advance online publication, November 7, 2016; 10.1038/onc.2016.400 Abstract | Full Text Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner OPEN J-Y Guo, H-S Hsu, S-W Tyan, F-Y Li, J-Y Shew, W-H Lee and J-Y Chen Oncogene 2017 36: 2457-2471; advance online publication, November 7, 2016; 10.1038/onc.2016.404 Abstract | Full Text Oncogenomics Top InFlo: a novel systems biology framework identifies cAMP-CREB1 axis as a key modulator of platinum resistance in ovarian cancer OPEN N Dimitrova, A B Nagaraj, A Razi, S Singh, S Kamalakaran, N Banerjee, P Joseph, A Mankovich, P Mittal, A DiFeo and V Varadan Oncogene 2017 36: 2472-2482; advance online publication, November 7, 2016; 10.1038/onc.2016.398 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.